SCHEDULE 13G/A: BlackRock Discloses 6.2% Passive Stake in Inogen Inc.
Ownership Disclosure
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 6.2% beneficial ownership stake in Inogen Inc.'s common stock as of June 30, 2025.
Summary
- BlackRock, Inc. reported beneficial ownership of 1,657,385 shares of Inogen Inc. common stock.
- This ownership represents 6.2% of the total outstanding common shares of Inogen Inc.
- BlackRock holds sole voting power over 1,615,843 shares and sole dispositive power over 1,657,385 shares.
- The filing is an Amendment No. 12 to a Schedule 13G, indicating a passive investment position.
- The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of Inogen Inc.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of an ownership stake, which is neutral in sentiment. It does not contain positive or negative operational news about the company.
Management Comments
- BlackRock, Inc. certifies that, to the best of its knowledge and belief, the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities.
Industry Context
This filing reflects a routine disclosure by a major institutional investor, BlackRock, Inc., regarding its passive ownership stake in Inogen Inc. It is a standard regulatory requirement for investors holding more than 5% of a company's shares and does not inherently indicate a strategic shift or specific industry trend beyond BlackRock's portfolio management activities.
Stakeholder Impact
- Shareholders: The disclosure of a significant passive stake by a major institutional investor like BlackRock can provide a degree of confidence or stability, indicating continued institutional interest in the company.
Key Dates
| Date | Description |
|---|---|
| 01/21/2025 | Date of execution of the Power of Attorney by BlackRock, Inc. |
| 06/30/2025 | Date of event requiring the filing of this statement (reporting period end date). |
| 07/17/2025 | Date of signature for the Schedule 13G filing. |
Keywords
BlackRock, Inogen Inc., Schedule 13G, beneficial ownership, common stock, institutional investment, passive stake, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.